Cenexi
Private Company
Funding information not available
Overview
Cenexi is a specialized CDMO with a core expertise in sterile injectable products, which constitute 70% of its turnover. The company has built a reputation on flexibility, significant capital investment (€80M over five years), and handling complex substances like hormones, narcotics, and biologics. As a private company, it serves pharmaceutical labs and biotechs, offering a full range of services from development to manufacturing under contract. Its agile organization and focus on sterile expertise position it in a high-growth segment of the pharmaceutical outsourcing market.
Technology Platform
Advanced sterile fill-finish manufacturing for injectables (pre-filled syringes, vials, ampoules) and non-sterile forms, with expertise in handling potent compounds (hormones, narcotics) and biologics.
Opportunities
Risk Factors
Competitive Landscape
Cenexi competes in the fragmented but competitive global CDMO market, especially within sterile injectables. It faces competition from large, diversified CDMOs (e.g., Lonza, Catalent) and other specialized European players. Its differentiation lies in its focused sterile expertise, agility, and significant recent investments in European-based capacity.